Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Head and Neck Cancer

Free Subscription Articles published in J Nucl Med Retrieve available abstracts of 46 articles: HTML format

Single Articles

July 2008
1. NAKAGAWA T , Yamada M, Suzuki Y
   18F-FDG Uptake in Reactive Neck Lymph Nodes of Oral Cancer: Relationship to Lymphoid Follicles.
   J Nucl Med. 2008;49:1053-9.
   PubMed     Related articles    Abstract available
   
   
   June 2008
2. NAHMIAS C , Lemmens C, Faul D, Carlson E, et al
   Does Reducing CT Artifacts from Dental Implants Influence the PET Interpretation in PET/CT Studies of Oral Cancer and Head and Neck Cancer?
   J Nucl Med. 2008;.
   PubMed     Related articles    Abstract available
   
   
   April 2008
3. SILBERSTEIN EB
   Reducing the incidence of 131I-induced sialadenitis: the role of pilocarpine.
   J Nucl Med. 2008;49:546-9.
   PubMed     Related articles    Abstract available
   
   
   March 2008
4. ONG SC , Schoder H, Lee NY, Patel SG, et al
   Clinical Utility of 18F-FDG PET/CT in Assessing the Neck After Concurrent Chemoradiotherapy for Locoregional Advanced Head and Neck Cancer.
   J Nucl Med. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
5. JAGER PL , Chirakal R, Marriott CJ, Brouwers AH, et al
   6-L-18F-Fluorodihydroxyphenylalanine PET in Neuroendocrine Tumors: Basic Aspects and Emerging Clinical Applications.
   J Nucl Med. 2008;.
   PubMed     Related articles    Abstract available
   
   
   January 2008
6. MULLER C , Forrer F, Schibli R, Krenning EP, et al
   SPECT Study of Folate Receptor-Positive Malignant and Normal Tissues in Mice Using a Novel 99mTc-Radiofolate.
   J Nucl Med. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. BURNISTON MT , Wilson DJ
   Radioiodine ablation outcomes after imaging with 123I or 131I: is no news good news?
   J Nucl Med. 2008;49:166.
   PubMed     Related articles   
   
   
   September 2007
8. LIU FY , Lin CY, Chang JT, Ng SH, et al
   18F-FDG PET Can Replace Conventional Work-up in Primary M Staging of Nonkeratinizing Nasopharyngeal Carcinoma.
   J Nucl Med. 2007;.
   PubMed     Related articles    Abstract available
   
   
   
9. WALTER MA , Turtschi CP, Schindler C, Minnig P, et al
   The Dental Safety Profile of High-Dose Radioiodine Therapy for Thyroid Cancer: Long-Term Results of a Longitudinal Cohort Study.
   J Nucl Med. 2007;.
   PubMed     Related articles    Abstract available
   
   
   
10. AIDE N , Bardet S
    Would Patient Selection Based on Both Calcitonin Blood Level and Doubling Time Improve 18F-FDG PET Sensitivity in Restaging of Medullary Thyroid Cancer?
    J Nucl Med. 2007;48:1574.
    PubMed     Related articles   
    
    
    August 2007
11. KIM KI , Kang JH, Chung JK, Lee YJ, et al
    Doxorubicin Enhances the Expression of Transgene Under Control of the CMV Promoter in Anaplastic Thyroid Carcinoma Cells.
    J Nucl Med. 2007;.
    PubMed     Related articles    Abstract available
    
    
    July 2007
12. GUO H , Zhu H, Xi Y, Zhang B, et al
    Diagnostic and Prognostic Value of 18F-FDG PET/CT for Patients with Suspected Recurrence from Squamous Cell Carcinoma of the Esophagus.
    J Nucl Med. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
13. JEONG HS , Chung MK, Son YI, Choi JY, et al
    Role of 18F-FDG PET/CT in Management of High-Grade Salivary Gland Malignancies.
    J Nucl Med. 2007;.
    PubMed     Related articles    Abstract available
    
    
    June 2007
14. SILBERSTEIN EB
    Comparison of Outcomes After 123I Versus 131I Preablation Imaging Before Radioiodine Ablation in Differentiated Thyroid Carcinoma.
    J Nucl Med. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
15. LAVELY WC , Goetze S, Friedman KP, Leal JP, et al
    Comparison of SPECT/CT, SPECT, and Planar Imaging with Single- and Dual-Phase 99mTc-Sestamibi Parathyroid Scintigraphy.
    J Nucl Med. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
16. HANDKIEWICZ-JUNAK D , Wloch J, Roskosz J, Krajewska J, et al
    Total Thyroidectomy and Adjuvant Radioiodine Treatment Independently Decrease Locoregional Recurrence Risk in Childhood and Adolescent Differentiated Thyroid Cancer.
    J Nucl Med. 2007;48:879-888.
    PubMed     Related articles    Abstract available
    
    
    
17. RAJENDRAN JG , Mankoff DA
    Beyond Detection: Novel Applications for PET Imaging to Guide Cancer Therapy.
    J Nucl Med. 2007;48:855-6.
    PubMed     Related articles   
    
    
    
18. ZITZMANN S , Kramer S, Mier W, Hebling U, et al
    Identification and evaluation of a new tumor cell-binding peptide, FROP-1.
    J Nucl Med. 2007;48:965-72.
    PubMed     Related articles    Abstract available
    
    
    May 2007
19. ITO S , Kato K, Ikeda M, Iwano S, et al
    Comparison of 18F-FDG PET and Bone Scintigraphy in Detection of Bone Metastases of Thyroid Cancer.
    J Nucl Med. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
20. KIM SY , Roh JL, Kim MR, Kim JS, et al
    Use of 18F-FDG PET for Primary Treatment Strategy in Patients with Squamous Cell Carcinoma of the Oropharynx.
    J Nucl Med. 2007;48:752-757.
    PubMed     Related articles    Abstract available
    
    
    
21. TROOST EG , Vogel WV, Merkx MA, Slootweg PJ, et al
    18F-FLT PET Does Not Discriminate Between Reactive and Metastatic Lymph Nodes in Primary Head and Neck Cancer Patients.
    J Nucl Med. 2007;48:726-735.
    PubMed     Related articles    Abstract available
    
    
    April 2007
22. HILDITCH TE , Bolster AA, Dempsey MF, Reed NS, et al
    Re: the so-called stunning of thyroid tissue.
    J Nucl Med. 2007;48:675-6.
    PubMed     Related articles   
    
    
    
23. ONG SC , Schoder H, Patel SG, Tabangay-Lim IM, et al
    Diagnostic Accuracy of 18F-FDG PET in Restaging Patients with Medullary Thyroid Carcinoma and Elevated Calcitonin Levels.
    J Nucl Med. 2007;48:501-507.
    PubMed     Related articles    Abstract available
    
    
    March 2007
24. KIM SY , Lee SW, Nam SY, Im KC, et al
    The Feasibility of 18F-FDG PET Scans 1 Month After Completing Radiotherapy of Squamous Cell Carcinoma of the Head and Neck.
    J Nucl Med. 2007;48:373-378.
    PubMed     Related articles    Abstract available
    
    
    February 2007
25. GERARD SK , Park HM
    Stunning effect.
    J Nucl Med. 2007;48:328-9.
    PubMed     Related articles   
    
    
    
26. ROH JL , Ryu CH, Choi SH, Kim JS, et al
    Clinical Utility of 18F-FDG PET for Patients with Salivary Gland Malignancies.
    J Nucl Med. 2007;48:240-246.
    PubMed     Related articles    Abstract available
    
    
    
27. SHAMMAS A , Degirmenci B, Mountz JM, McCook BM, et al
    18F-FDG PET/CT in Patients with Suspected Recurrent or Metastatic Well-Differentiated Thyroid Cancer.
    J Nucl Med. 2007;48:221-226.
    PubMed     Related articles    Abstract available
    
    
    January 2007
28. QUON A , Fischbein NJ, McDougall IR, Le QT, et al
    Clinical Role of 18F-FDG PET/CT in the Management of Squamous Cell Carcinoma of the Head and Neck and Thyroid Carcinoma.
    J Nucl Med. 2007;48.
    PubMed     Related articles    Abstract available
    
    
    
29. KOLBERT KS , Pentlow KS, Pearson JR, Sheikh A, et al
    Prediction of Absorbed Dose to Normal Organs in Thyroid Cancer Patients Treated with 131I by Use of 124I PET and 3-Dimensional Internal Dosimetry Software.
    J Nucl Med. 2007;48:143-9.
    PubMed     Related articles    Abstract available
    
    
    
30. CHEN YK , Su CT, Chi KH, Cheng RH, et al
    Utility of 18F-FDG PET/CT Uptake Patterns in Waldeyer's Ring for Differentiating Benign from Malignant Lesions in Lateral Pharyngeal Recess of Nasopharynx.
    J Nucl Med. 2007;48:8-14.
    PubMed     Related articles    Abstract available
    
    
    
31. LASSMANN M , Hanscheid H
    Spatial dose mapping for individualizing radioiodine treatment.
    J Nucl Med. 2007;48:2-4.
    PubMed     Related articles   
    
    
    December 2006
32. SGOUROS G , Song H, Ladenson PW, Wahl RL, et al
    Lung Toxicity in Radioiodine Therapy of Thyroid Carcinoma: Development of a Dose-Rate Method and Dosimetric Implications of the 80-mCi Rule.
    J Nucl Med. 2006;47:1977-1984.
    PubMed     Related articles    Abstract available
    
    
    
33. MULLER C , Bruhlmeier M, Schubiger PA, Schibli R, et al
    Effects of antifolate drugs on the cellular uptake of radiofolates in vitro and in vivo.
    J Nucl Med. 2006;47:2057-64.
    PubMed     Related articles    Abstract available
    
    
    
34. SONG H , He B, Prideaux A, Du Y, et al
    Lung dosimetry for radioiodine treatment planning in the case of diffuse lung metastases.
    J Nucl Med. 2006;47:1985-94.
    PubMed     Related articles    Abstract available
    
    
    November 2006
35. GAYED IW , Liu HH, Yusuf SW, Komaki R, et al
    The Prevalence of Myocardial Ischemia After Concurrent Chemoradiation Therapy as Detected by Gated Myocardial Perfusion Imaging in Patients with Esophageal Cancer.
    J Nucl Med. 2006;47:1756-1762.
    PubMed     Related articles    Abstract available
    
    
    October 2006
36. TRAVIS CC , Stabin MG
    131I ablation treatment in young females after the Chernobyl accident.
    J Nucl Med. 2006;47:1723-7.
    PubMed     Related articles    Abstract available
    
    
    
37. TUTTLE RM , Leboeuf R, Robbins RJ, Qualey R, et al
    Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer.
    J Nucl Med. 2006;47:1587-91.
    PubMed     Related articles    Abstract available
    
    
    
38. REINERS C , Lassmann M, Hanscheid H
    A perspective on post-Chernobyl radioablation in young females.
    J Nucl Med. 2006;47:1563-4.
    PubMed     Related articles   
    
    
    September 2006
39. MARTINEZ-DUNCKER C , Hurtado-Lopez LM
    18F-FDG PET of Thyroid Nodules with Inconclusive Cytologic Results.
    J Nucl Med. 2006;47:1555.
    PubMed     Related articles   
    
    
    
40. SISSON JC , Avram AM, Lawson SA, Gauger PG, et al
    The so-called stunning of thyroid tissue.
    J Nucl Med. 2006;47:1406-12.
    PubMed     Related articles    Abstract available
    
    
    
41. WOOLFENDEN JM
    Thyroid stunning revisited.
    J Nucl Med. 2006;47:1403-5.
    PubMed     Related articles   
    
    
    August 2006
42. BLASER D , Maschauer S, Kuwert T, Prante O, et al
    In Vitro Studies on the Signal Transduction of Thyroidal Uptake of 18F-FDG and 131I-Iodide.
    J Nucl Med. 2006;47:1382-8.
    PubMed     Related articles    Abstract available
    
    
    
43. LUBBERINK M , van Schie A, de Jong HW, van Dongen GA, et al
    Acquisition Settings for PET of 124I Administered Simultaneously with Therapeutic Amounts of 131I.
    J Nucl Med. 2006;47:1375-1381.
    PubMed     Related articles    Abstract available
    
    
    
44. PRYMA DA , Schoder H, Gonen M, Robbins RJ, et al
    Diagnostic Accuracy and Prognostic Value of 18F-FDG PET in Hurthle Cell Thyroid Cancer Patients.
    J Nucl Med. 2006;47:1260-1266.
    PubMed     Related articles    Abstract available
    
    
    
45. YUAN S , Yu Y, Chao KS, Fu Z, et al
    Additional Value of PET/CT over PET in Assessment of Locoregional Lymph Nodes in Thoracic Esophageal Squamous Cell Cancer.
    J Nucl Med. 2006;47:1255-1259.
    PubMed     Related articles    Abstract available
    
    
    February 2006
46. KRAEBER-BODERE F , Rousseau C, Bodet-Milin C, Ferrer L, et al
    Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial.
    J Nucl Med. 2006;47:247-55.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: